Ferroptosis Regulator Information
General Information of the Ferroptosis Regulator (ID: REG10300)
Full List of the Ferroptosis Target of This Regulator and Corresponding Disease/Drug Response(s)
DAZAP1
can regulate the following target(s), and cause disease/drug response(s). You can browse detail information of target(s) or disease/drug response(s).
Browse Target
Browse Disease
Cystine/glutamate transporter (SLC7A11) [Driver; Suppressor]
In total 1 item(s) under this target | |||||
Experiment 1 Reporting the Ferroptosis Target of This Regulator | [1] | ||||
Target for Ferroptosis | Suppressor | ||||
Responsed Disease | Hepatocellular carcinoma | ICD-11: 2C12 | |||
Pathway Response | Fatty acid metabolism | hsa01212 | |||
Ferroptosis | hsa04216 | ||||
Cell Process | Cell ferroptosis | ||||
Cell proliferation | |||||
Cell migration | |||||
Cell invasion | |||||
In Vitro Model |
Hep-G2 cells | Hepatoblastoma | Homo sapiens | CVCL_0027 | |
SMMC-7721 cells | Endocervical adenocarcinoma | Homo sapiens | CVCL_0534 | ||
Hep 3B2.1-7 cells | Hepatocellular carcinoma | Homo sapiens | CVCL_0326 | ||
BEL-7402 cells | Endocervical adenocarcinoma | Homo sapiens | CVCL_5492 | ||
Huh-7 cells | Hepatocellular carcinoma | Homo sapiens | CVCL_0336 | ||
L-02 cells | Endocervical adenocarcinoma | Homo sapiens | CVCL_6926 | ||
In Vivo Model |
Male BALB/c nude mice (4-5 weeks, 14-18 g) were purchased from Vital River Laboratories (Beijing, China). We randomly (random number grouping method) divided the mice into five groups: the blank group, the DMSO group, the SF group, the SF + sh-NC group and the SF + sh-DAZAP1 group. For SF-intervention mice, we dissolved 10 mg/kg of SF into 0.2 ml DMSO and injected the mixture intraperitoneally every other day for two weeks. 1 x 107 cells (with or without lentivirus) suspended in 500 ul of ice-cold PBS were subcutaneously injected into the left flank of mice.
Click to Show/Hide
|
||||
Response regulation | DAZAP1 knockdown by small interfering RNA markedly inhibited hepatocellular carcinoma (HCC) cell proliferation, migration and invasion. At the mechanistic level, DAZAP1 was identified as a potent inhibitor of ferroptosis and an efficient binding partner of SLC7A11 mRNA. | ||||
Hepatocellular carcinoma [ICD-11: 2C12]
In total 1 item(s) under this disease | |||||
Experiment 1 Reporting the Ferroptosis-centered Disease Response | [1] | ||||
Target Regulator | DAZ-associated protein 1 (DAZAP1) | Protein coding | |||
Pathway Response | Fatty acid metabolism | hsa01212 | |||
Ferroptosis | hsa04216 | ||||
Cell Process | Cell ferroptosis | ||||
Cell proliferation | |||||
Cell migration | |||||
Cell invasion | |||||
In Vitro Model |
Hep-G2 cells | Hepatoblastoma | Homo sapiens | CVCL_0027 | |
SMMC-7721 cells | Endocervical adenocarcinoma | Homo sapiens | CVCL_0534 | ||
Hep 3B2.1-7 cells | Hepatocellular carcinoma | Homo sapiens | CVCL_0326 | ||
BEL-7402 cells | Endocervical adenocarcinoma | Homo sapiens | CVCL_5492 | ||
Huh-7 cells | Hepatocellular carcinoma | Homo sapiens | CVCL_0336 | ||
L-02 cells | Endocervical adenocarcinoma | Homo sapiens | CVCL_6926 | ||
In Vivo Model |
Male BALB/c nude mice (4-5 weeks, 14-18 g) were purchased from Vital River Laboratories (Beijing, China). We randomly (random number grouping method) divided the mice into five groups: the blank group, the DMSO group, the SF group, the SF + sh-NC group and the SF + sh-DAZAP1 group. For SF-intervention mice, we dissolved 10 mg/kg of SF into 0.2 ml DMSO and injected the mixture intraperitoneally every other day for two weeks. 1 x 107 cells (with or without lentivirus) suspended in 500 ul of ice-cold PBS were subcutaneously injected into the left flank of mice.
Click to Show/Hide
|
||||
Response regulation | DAZAP1 knockdown by small interfering RNA markedly inhibited hepatocellular carcinoma (HCC) cell proliferation, migration and invasion. At the mechanistic level, DAZAP1 was identified as a potent inhibitor of ferroptosis and an efficient binding partner of SLC7A11 mRNA. | ||||